Saturday, July 11, 2026
🇺🇸 FDA

Intelligence · Clinical pipeline

Phase II Pipeline Programs

Proof-of-concept and dose-finding clinical programs in Phase II development.

Programs 7,238
Sponsors 1,771
Drugs 4,798

Quick answer

NovaPharmaNews tracks 7,238 phase ii pharmaceutical pipeline programs from ClinicalTrials.gov. Proof-of-concept and dose-finding clinical programs in Phase II development.

Top sponsors

Pipeline programs

Page 37 of 151

  1. CSET N°2020/3138

    The George Institute

    Advanced hepatocellular carcinoma

    phase 2 other active

    1 trial

  2. CSET n° 2020/3210

    The George Institute

    Untreated small triple negative breast cancer

    phase 2 other active

    1 trial

  3. CSIIT-Q115

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Small Cell Lung Cancer

    phase 2 small molecule active

    1 trial

  4. CSJ117

    Novartis Pharmaceuticals

    Asthma

    phase 2 small molecule terminated

    2 trials

  5. CT-011

    United Therapeutics Europe Ltd

    Multiple Myeloma

    phase 2 small molecule completed

    1 trial

  6. CT-011

    Teva Pharma GmbH

    Chronic Hepatitis C

    phase 2 small molecule terminated

    1 trial

  7. CT-011

    Teva Pharma GmbH

    Primary Hepatocellular Carcinoma

    phase 2 small molecule terminated

    1 trial

  8. CT-AMT-130-02

    uniQure biopharma B.V.

    Huntington’s Disease

    phase 2 small molecule active

    1 trial

  9. CT-P1-002

    Lacuna Pharma Pty Ltd

    Cardiogenic shock due to Acute Coronary Syndrome, cardiogenic shock of septic origin or cardiogenic shock due to Acute decompensated Heart Failure

    phase 2 other active

    1 trial

  10. CT053PTSA

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Renal Cell Cancer Metastatic

    phase 2 small molecule terminated

    1 trial

  11. CT053PTSA

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Advanced NSCLC

    phase 2 small molecule terminated

    1 trial

  12. CT053PTSA

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Non-small Cell Lung Cancer

    phase 2 small molecule completed

    1 trial

  13. CT1812

    COGNITION THERAPEUTICS INC

    Mild to Moderate Alzheimer's Disease

    phase 2 small molecule completed

    1 trial

  14. CT1812

    COGNITION THERAPEUTICS INC

    Early Alzheimer's Disease

    phase 2 small molecule active

    1 trial

  15. CT1812

    COGNITION THERAPEUTICS INC

    Dementia With Lewy Bodies

    phase 2 small molecule completed

    1 trial

  16. CT1812

    COGNITION THERAPEUTICS INC

    Alzheimer's Disease

    phase 2 small molecule completed

    1 trial

  17. CT1812

    COGNITION THERAPEUTICS INC

    Alzheimer Disease

    phase 2 small molecule completed

    3 trials

  18. CT7001, PF-07850327 round

    Pfizer Australia Pty Ltd

    Advanced or Metastatic Breast Cancer

    phase 2 small molecule active

    1 trial

  19. CTI-1601

    Larimar Therapeutics

    Friedreich Ataxia

    phase 2 mab active

    4 trials

  20. CTIN816A12201

    Novartis Pharmaceuticals

    Acute kidney injury

    phase 2 small molecule active

    1 trial

  21. CTIN816B12202

    Novartis Pharmaceuticals

    Sepsis associated acute kidney injury

    phase 2 small molecule active

    1 trial

  22. CTP-VLP-002

    CanSino Biologics

    Poliomyelitis

    phase 2 mab active

    1 trial

  23. CTQJ230A12203

    Novartis Pharmaceuticals

    Calcific Aortic Valve Stenosis

    phase 2 small molecule active

    1 trial

  24. CTRIAL-IE 19-34

    Ningbo Cancer Hospital

    Newly diagnosed Multiple Myeloma

    phase 2 small molecule active

    1 trial

  25. CTX-009

    Compass Therapeutics

    Glioblastoma

    phase 2 small molecule active

    1 trial

  26. CTX-009

    Compass Therapeutics

    Metastatic Colorectal Cancer

    phase 2 small molecule completed

    1 trial

  27. CTX-009 (ABL001)

    Compass Therapeutics

    P1b: Advanced Solid Tumors

    phase 2 small molecule terminated

    1 trial

  28. CTX-4430

    CNS Pharmaceuticals

    Acne Vulgaris

    phase 2 small molecule completed

    1 trial

  29. CTX001-121

    Vertex Pharmaceuticals (Australia) Pty.

    Severe sickle cell disease (SCD)

    phase 2 small molecule active

    1 trial

  30. CTX110

    S.A.

    B-cell Malignancy

    phase 2 mab terminated

    1 trial

  31. CTX112

    S.A.

    B-cell Lymphoma

    phase 2 mab active

    1 trial

  32. CTX112

    S.A.

    Warm Autoimmune Hemolytic Anemia (WAIHA)

    phase 2 mab active

    1 trial

  33. CTX131

    S.A.

    Clear Cell Renal Cell Carcinoma

    phase 2 mab completed

    1 trial

  34. CTX131

    S.A.

    T Cell Lymphoma

    phase 2 mab completed

    1 trial

  35. CUE-101

    Cue Biopharma

    Head and Neck Squamous Cell Carcinoma

    phase 2 small molecule active

    1 trial

  36. CUE-101

    Cue Biopharma

    Oropharyngeal Squamous Cell Carcinoma

    phase 2 small molecule active

    1 trial

  37. CUVITRU - Ig subcutaneous human 20%

    Takeda

    COPD Exacerbation Acute

    phase 2 mab active

    1 trial

  38. CVAY736A2103

    Novartis Pharmaceuticals

    Sjögren's syndrome

    phase 2 small molecule active

    1 trial

  39. CVAY736A2202

    Novartis Pharmaceuticals

    Rheumatoid Arthritis, Sjögren’s Disease, Systemic Lupus erythematosus

    phase 2 small molecule active

    1 trial

  40. CVAY736Q12202B

    Novartis Pharmaceuticals

    Immune thrombocytopenia (ITP) Warm autoimmune hemolytic anemia (wAIHA)

    phase 2 small molecule active

    1 trial

  41. CVAY736S12201

    Novartis Pharmaceuticals

    Diffuse cutaneous systemic sclerosis (dcSSc)

    phase 2 small molecule active

    1 trial

  42. CVHB937A12201

    Novartis Pharmaceuticals

    Alzheimer’s disease

    phase 2 small molecule active

    1 trial

  43. CVHB937B12201

    Novartis Pharmaceuticals

    Amyotrophic Lateral Sclerosis (ALS)

    phase 2 small molecule active

    1 trial

  44. CX-072

    CytomX Therapeutics

    Solid Tumor

    phase 2 small molecule terminated

    2 trials

  45. CX-2009

    CytomX Therapeutics

    Neoplasms

    phase 2 small molecule completed

    1 trial

  46. CX-2009

    CytomX Therapeutics

    Solid Tumor, Adult

    phase 2 small molecule terminated

    1 trial

  47. CX-2029

    CytomX Therapeutics

    Solid Tumor, Adult

    phase 2 small molecule completed

    1 trial

  48. CX-8998

    Jazz Pharmaceuticals Ireland Limited

    Essential Tremor

    phase 2 small molecule completed

    1 trial

Frequently asked questions

How many Phase II pipeline programs are in the directory?

7,238 published programs match this development stage in our ClinicalTrials.gov index.

What defines this pipeline stage?

Phase and status reflect ClinicalTrials.gov registry fields at last sync. See our clinical trial phases reference for methodology.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.